Cargando…
Chemotherapeutic Risk lncRNA-PVT1 SNP Sensitizes Metastatic Colorectal Cancer to FOLFOX Regimen
Recent studies have identified that long noncoding RNA (lncRNA) might affect the responses to anticancer drug treatment, including colorectal cancer (CRC). However, the association between single-nucleotide polymorphisms (SNPs) in PVT1 and the chemotherapy response in metastatic colorectal cancer ha...
Autores principales: | Wu, Shenshen, Yang, Xi, Tang, Weiyan, Familiari, Giuseppe, Relucenti, Michela, Aschner, Michael, Li, Xiaobo, Chen, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008320/ https://www.ncbi.nlm.nih.gov/pubmed/35433465 http://dx.doi.org/10.3389/fonc.2022.808889 |
Ejemplares similares
-
Epstein–Barr Virus‐Encoded MicroRNA‐BART18‐3p Promotes Colorectal Cancer Progression by Targeting De Novo Lipogenesis
por: Meng, Qingtao, et al.
Publicado: (2022) -
HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
por: Xu, Jie, et al.
Publicado: (2021) -
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1
por: Wu, Tingrui, et al.
Publicado: (2022) -
Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer
por: Wang, Yajie, et al.
Publicado: (2019) -
lncRNA PVT1: a novel oncogene in multiple cancers
por: Li, Ruiming, et al.
Publicado: (2022)